Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Oct 06 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-06-2022-7

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 06-Oct-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases